Cargando…

What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?

PURPOSE: Prior studies have suggested that (18)F-FDG PET/CT can help characterize adrenal lesions and differentiate adrenal metastases from benign lesions. The aim of this study was to assess the value of (18)F-FDG PET/CT for the differentiation of malignant from benign adrenal lesions. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunikowska, Jolanta, Matyskiel, Renata, Toutounchi, Sadegh, Grabowska-Derlatka, Laretta, Koperski, Łukasz, Królicki, Leszek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226932/
https://www.ncbi.nlm.nih.gov/pubmed/25027709
http://dx.doi.org/10.1007/s00259-014-2844-1
_version_ 1782343697383292928
author Kunikowska, Jolanta
Matyskiel, Renata
Toutounchi, Sadegh
Grabowska-Derlatka, Laretta
Koperski, Łukasz
Królicki, Leszek
author_facet Kunikowska, Jolanta
Matyskiel, Renata
Toutounchi, Sadegh
Grabowska-Derlatka, Laretta
Koperski, Łukasz
Królicki, Leszek
author_sort Kunikowska, Jolanta
collection PubMed
description PURPOSE: Prior studies have suggested that (18)F-FDG PET/CT can help characterize adrenal lesions and differentiate adrenal metastases from benign lesions. The aim of this study was to assess the value of (18)F-FDG PET/CT for the differentiation of malignant from benign adrenal lesions. METHODS: This retrospective study included 85 patients (47 men and 38 women, age 63.8 ± 10.8 years) who had undergone (18)F-FDG PET/CT (60 min after injection 300 – 370 MBq (18)F-FDG; Biograph 64 scanner) for evaluation of 102 nonsecreting adrenal masses. For semiquantitative analysis, the maximum standardized uptake value (SUVmax), adrenal to liver (T/L) SUVmax ratio, mean CT attenuation value and tumour diameter were measured in all lesions and compared with the pathological findings. RESULTS: Malignant adrenal tumours (68 % of evaluated tumours) had a significantly higher mean SUVmax (13.0 ± 7.1 vs. 3.7 ± 3.0), a higher T/L SUVmax ratio (4.2 ± 2.6 vs. 1.0 ± 0.9), a higher CT attenuation value (31.9 ± 16. 7 HU vs. 0.2 ± 25.8 HU) and a greater diameter (43.6 ± 23.7 mm vs. 25.6 ± 13.3 mm) than benign lesions. The false-positive findings were tuberculosis and benign phaeochromocytoma. Based on ROC analysis, a T/L SUVmax ratio >1.53, an adrenal SUVmax >5.2, an attenuation value >24 HU and a tumour diameter >30 mm were chosen as the optimal cut-off values for differentiating malignant from benign tumours. The areas under the ROC curves for the selected cut-off values were 0.96, 0.96, 0.88 and 0.77, respectively. A multivariate logistic regression model revealed that the T/L SUVmax ratio was an independent prognostic factor for malignancy (p < 0.001); a CT attenuation value of >25 HU and a tumour diameter >30 mm had no additional individual importance in the diagnosis of malignancy. CONCLUSION: Using a T/L SUVmax ratio >1.53 and an adrenal SUVmax >5.2 in (18)F-FDG PET/CT led to high diagnostic sensitivity, specificity and negative predictive value for characterizing adrenal tumours. The diagnostic accuracies of the two parameters were comparable, but T/L SUVmax ratio was an independent predictor of malignancy.
format Online
Article
Text
id pubmed-4226932
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-42269322014-11-13 What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions? Kunikowska, Jolanta Matyskiel, Renata Toutounchi, Sadegh Grabowska-Derlatka, Laretta Koperski, Łukasz Królicki, Leszek Eur J Nucl Med Mol Imaging Original Article PURPOSE: Prior studies have suggested that (18)F-FDG PET/CT can help characterize adrenal lesions and differentiate adrenal metastases from benign lesions. The aim of this study was to assess the value of (18)F-FDG PET/CT for the differentiation of malignant from benign adrenal lesions. METHODS: This retrospective study included 85 patients (47 men and 38 women, age 63.8 ± 10.8 years) who had undergone (18)F-FDG PET/CT (60 min after injection 300 – 370 MBq (18)F-FDG; Biograph 64 scanner) for evaluation of 102 nonsecreting adrenal masses. For semiquantitative analysis, the maximum standardized uptake value (SUVmax), adrenal to liver (T/L) SUVmax ratio, mean CT attenuation value and tumour diameter were measured in all lesions and compared with the pathological findings. RESULTS: Malignant adrenal tumours (68 % of evaluated tumours) had a significantly higher mean SUVmax (13.0 ± 7.1 vs. 3.7 ± 3.0), a higher T/L SUVmax ratio (4.2 ± 2.6 vs. 1.0 ± 0.9), a higher CT attenuation value (31.9 ± 16. 7 HU vs. 0.2 ± 25.8 HU) and a greater diameter (43.6 ± 23.7 mm vs. 25.6 ± 13.3 mm) than benign lesions. The false-positive findings were tuberculosis and benign phaeochromocytoma. Based on ROC analysis, a T/L SUVmax ratio >1.53, an adrenal SUVmax >5.2, an attenuation value >24 HU and a tumour diameter >30 mm were chosen as the optimal cut-off values for differentiating malignant from benign tumours. The areas under the ROC curves for the selected cut-off values were 0.96, 0.96, 0.88 and 0.77, respectively. A multivariate logistic regression model revealed that the T/L SUVmax ratio was an independent prognostic factor for malignancy (p < 0.001); a CT attenuation value of >25 HU and a tumour diameter >30 mm had no additional individual importance in the diagnosis of malignancy. CONCLUSION: Using a T/L SUVmax ratio >1.53 and an adrenal SUVmax >5.2 in (18)F-FDG PET/CT led to high diagnostic sensitivity, specificity and negative predictive value for characterizing adrenal tumours. The diagnostic accuracies of the two parameters were comparable, but T/L SUVmax ratio was an independent predictor of malignancy. Springer Berlin Heidelberg 2014-07-16 2014 /pmc/articles/PMC4226932/ /pubmed/25027709 http://dx.doi.org/10.1007/s00259-014-2844-1 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Original Article
Kunikowska, Jolanta
Matyskiel, Renata
Toutounchi, Sadegh
Grabowska-Derlatka, Laretta
Koperski, Łukasz
Królicki, Leszek
What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
title What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
title_full What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
title_fullStr What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
title_full_unstemmed What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
title_short What parameters from (18)F-FDG PET/CT are useful in evaluation of adrenal lesions?
title_sort what parameters from (18)f-fdg pet/ct are useful in evaluation of adrenal lesions?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226932/
https://www.ncbi.nlm.nih.gov/pubmed/25027709
http://dx.doi.org/10.1007/s00259-014-2844-1
work_keys_str_mv AT kunikowskajolanta whatparametersfrom18ffdgpetctareusefulinevaluationofadrenallesions
AT matyskielrenata whatparametersfrom18ffdgpetctareusefulinevaluationofadrenallesions
AT toutounchisadegh whatparametersfrom18ffdgpetctareusefulinevaluationofadrenallesions
AT grabowskaderlatkalaretta whatparametersfrom18ffdgpetctareusefulinevaluationofadrenallesions
AT koperskiłukasz whatparametersfrom18ffdgpetctareusefulinevaluationofadrenallesions
AT krolickileszek whatparametersfrom18ffdgpetctareusefulinevaluationofadrenallesions